Teaching Faculty

Elliott Crooke, PhD

Department Chair

PhD University of California at Los Angeles

Control of the initiation of chromosomal replication; role of polyphosphates in cellular responses to environmental stresses

Karen Brotherton-Julien, MS


MS, Biochemistry & Molecular Biology, Georgetown University

Leonard Bazar, PhD

Associate Professor

PhD, Molecular Pathology, Georgetown University

You-Shin Chen, PhD


PhD, Biochemistry & Molecular Biology Program, Georgetown University

Jack G. Chirikjian, PhD

Professor, Director of Biotechnology Program

PhD, biochemistry from Rutgers University. PhD, in biochemistry/molecular biology from Princeton University.

Robert Donahue, MA


MA, Biological Sciences, University of Texas, Austin

Khuyen Mai, MS


MS, Biochemistry & Molecular Biology, Georgetown University

Vasna Nontanovan, MS

Associate Director of Biotechnology Program

MS, Biochemistry & Molecular Biology, Georgetown University

Sona Vasudevan, PhD


PhD, Medical Bioph, University of Toronto, Canada

Ken Wasserman, PhD

Assistant Professor

PhD, Microbiology, University of Pittsburgh

Biochemistry & Molecular & Cellular Biology Department Faculty


Peter M. Andrews, PhD

Tulane University, New Orleans, LA

Evaluating ways to improve the ability of NSAIDs to induce programmed cell death (apoptosis) of cancer cells

Jack G. Chirikjian, PhD

Rutgers University, New Brunswick, NJ

Serial entrepreneur for building biotechnology companies

Elliott Crooke, PhD

Department Chair

PhD University of California at Los Angeles

Control of the initiation of chromosomal replication; role of polyphosphates in cellular responses to environmental stresses

Daniel Djakiew, PhD

University of Newcastle, Australia

Characterizing the interaction of neurotrophins with the Trk receptor in the proliferation of prostate tumor cells, and conversely, with the p75NTR receptor in the induction of apoptosis.

Martin Dym, PhD

McGill University, Montreal, Canada

Germ cell gene therapy

Jessica Jones, PhD

Georgetown University

Protein biochemistry; DNA recombination and repair; ubiquitin conjugation; vertebrate immune systems

Usha S Kasid, PhD

Punjab University

Molecular tumor biology; Raf-1 kinase and signal transduction; regulation of tumor growth and radiation

Mary Beth Martin, PhD

University of Medicine and Dentistry, New Jersey

Role of estrogen and the estrogen receptor in the etiology and progression of breast cancer

Hiroshi Nakai, PhD

University of Colorado

Gene amplification and chromosomal rearrangement promoted by movable genetic elements

Vicente Notario, PhD

University of Salamanca

Mechanisms of oncogenesis; environmental carcinogens; molecular genetics, with emphasis on yeast genetic

Paul Roepe, PhD

Boston University

Drug resistance mechanisms of membrane transport; gene expression in drug resistant tumor cells

Carlos Suarez-Quian, PhD

Harvard University

Investigation of testicular function using cell biology methodology.

Sona Vasudevan, PhD

University of Toronto, Canada

Structure-Function relationships of cancer related genes, Antigen-Antibody interactions, Ligand-Protein interactions, Drug-Design and Systems Medicine

Associate Professors

Partha P. Banerjee, PhD

Visva-Bharati University, Santiniketan, India

Understanding how androgen-independent prostate cancer cells develop, survive and proliferate in an androgen-free environment

Leonard Bazar, PhD

Georgetown University

The study of connectrons that induce critical genes required for viability of antibiotic-resistant prokaryotes

Mark Danielsen, PhD

University of South Carolina

Molecular biology of steroid receptors and their role in growth, differentiation, and the development of cancer

Nathan Edwards, PhD

Cornell University

Informatics of proteomics by mass spectrometry

Ian G. Gallicano, PhD

Arizona State University

Cellular adhesion during early embryogenesis in mammals

Timothy J. Jorgensen, PhD

The Johns Hopkins University, Baltimore, MD

Mechanisms of radiation-induced signal transduction and DNA repair, to identify molecular targets for sensitizing tumors to radiotherapy

Dean S. Rosenthal, PhD

Northwestern University

Epithelial differentation; apoptosis; carcinogenesis

Cynthia M. Simbulan-Rosenthal, PhD

Nagoya University School of Medicine , Japan

Breast carcinogenesis; apoptosis; DNA replication and repair

Assistant Professor

Ken Wasserman, PhD

University of Pittsburgh


Instructors & Research Associates

You-Shin Chen, PhD


PhD, Biochemistry & Molecular Biology Program, Georgetown University

Robert Donahue, MA


MA, Biological Sciences, University of Texas, Austin

Anirudh Gaur, MS

Research Associate

MS Biotechnology, Georgetown University

Khuyen N Mai, MS


MS Biotechnology, Georgetown University

Adjunct Faculty

Matthew Arnold, MS, MBA

MBA, University of Michigan
MS, Georgetown University
BS, US Naval Academy

Professional Experience:

  • Vice President, Head of Operations, Innovative Medicines and Early Development (AstraZeneca’s Small Molecule Biotech Unit)
  • Vice President, Chief of Staff, MedImmune
  • Director, Strategic Planning, Product Development, Supply Chain Risk Management, Amgen
  • Instructor, California State University MS Biotechnology Program
  • Officer, US Navy

Richard Ascione, MS, PhD

MS & PhD, Molecular Biology, Princeton University

Professional Experience:

  • Biotech/Healthcare Research Analyst, MDB Capital Group and Fairlook Investment Advisors, LLC.
  • Industry Expert, Chief Scientific Office/Consultant, OnkoLogix LTD/ImmunoLogix LTD
  • Adjunct Professor, Toxicology, Adelphi University
  • Biotech and Healthcare Specialist, Director, Institutional Research Group, Fagenson & Co., Inc., NYSE and NASD
  • Chief Scientific Officer, ViRexx Medical Corporation
  • Research Director and Vice President of Research, Aphton Laboratory of Molecular Medicine and Aphton BioPharma Inc
  • Professor, (Tenured) Department of Experiemtnal Oncology, Medical University of South Carolina, and the Hollings Cancer Center, Charleston SC
  • Senior Research Scientist, & Deputy Chief, Laboratory of Molecular Oncology, National Cancer Institute, Division of Cancer Institute, Division of Cancer Etiology, Frederick Cancer Research Facility, National Institutes of Health, Frederick, MD

Robert Burleson, MBA

MBA, Accounting/Finance, Marymount University, Arlington, Virginia

Professional Experience:

  • Paragon, CFO
  • Thermo Trilogy Corp., CFO
  • National Asthma and Allergy Systems, LP, CFO
  • Ringling Bros. and Barnum & Bailey Combined Shows, Inc.
  • Director of Financial Analysis
  • Controller, Retail Division
  • Director of Corporate Financial Planning
  • Senior Financial Analyst
  • MBI Business Centers, Inc., Financial Analyst

Charles Dormer, MPhil, MS

MPhil, Organizational Dynamics, University of Pennsylvania
MS, Organizational Dynamics, University of Pennsylvania

Member, Institute of Leadership and Management, International Coaching Federation, Life Sciences Pennsylvania; Board Member, Local Philadelphia Chapter of the Institute of Management Consultants; Hogan Assessment Certified, Level 7 qualification in Executive Coaching and Mentoring

Professional Experience:

President and Founder, APEX STP, LLC, Executive Coach/Consulting Firm

Charles Dormer brings over 35 years of experience in healthcare and pharmaceutical R&D to his executive coaching and consulting work. In his extensive corporate career, he has worked for some of the top pharmaceutical companies including SmithKline Beecham, GlaxoSmithKline, Wyeth, Pfizer and AstraZeneca. Charles held a number of roles ranging from strategy definition and implementation, management, research, operations, reengineering, organization development, business redesign, portfolio and alliance management and chief of staff activities. He has been involved in major mergers and acquisitions within the pharmaceutical industry and major change efforts.

Stephanie Duatschek, MBA

BS Biochemistry, University of Maryland, Baltimore, MD
MBA, Strategic Marketing, Fuqua School of Business, Duke University, Chapel Hill,, NC

Professional Experience:

  • Vice President, Commercial Operations, MedImmune, Gaithersburg, MD
  • Ms. Duatscheck had roles within global clinical drug development, project management, portfolio management and business development at Quintiles Transnational, Otsuka Pharmaceuticals and BioReg Associates.

Lee Eiden, PhD

PhD, Pharmacology, University of Kansas, Lawrence, Kansas

Professional Experience:

  • Chief, Section on Molecular Neuroscience, NIMH, NIH
  • Adjunct Associate Professor, Department of Georgetown University
  • Editorial Board, and Bioinformatics Committee, Science Signaling
  • Editorial Boards of Journal of Biological Chemistry, Peptides, Cellular and Molecular Neurobiology

Research Interests:

  • Establishment of chemical coding in the nervous system via regulation of neurotransmitter transporter, neurotransmitter biosynthetic enzyme, and neuropeptide gene expression.
  • Microarray-based gene discovery in neuroprotection and stress-related affective disorders.
  • Identification of novel molecular components for neuropeptide signaling pathways in stress.
  • Dysregulation of biosynthesis and expression of informational molecules in encephalopathy and neurodegenerative disease.

Mike Gove, MS

MS, Biochemistry, University of Maine, Orono, Maine

Professional Experience:

  • Biotechnology Consultant, Gaithersburg, MD
  • Life Technologies, Inc., Rockville, MD
  • Sr. Marketing Manager, Segmentation, Americas Research Products Division
  • Sr. Marketing Manager, Brand, Americas Research Products Division
  • Corporate Planning Manager
  • Business Director, Immunology Venture, New Business Division
  • Director of Marketing, Research Products Division
  • Manager of Marketing & Technical Service, BRL Division
  • Group Product Manager, Bethesda Research Laboratories
  • Manager of the Biological Chemistry Lab, Bethesda Research Laboratories
  • Scientist, Bethesda Research Laboratories

Dan Hartmann, PhD

BS, McGill University
MS, Queen's University
PhD, McGill University

Professional Experience:

  • Adjunct Professor, Department of Pathology (2012- ), Department of Biochemistry and Molecular & Cellular Biology(2006- ), Georgetown University School of Medicine
  • Scientific Director, Molecular Diagnostic Laboratory
  • Professor, Department of Pathology, Georgetown University School of Medicine., (1990-2011)

Arthur House, JD

  • Principal, Paley Rothman Goldstein Rosenberg Eig & Cooper

Edward Kisailus, PhD

BA, Biological Science, University of the Pacific
MS and PhD, Chemical Ecology, University of California, Davis

Professional Experience:

  • Director, BioLect, Inc.

Richard Kjeldgaard

Professional Experience:

  • Intellectual property attorney experienced in policies and laws of developing and developed countries that affect global opportunities and strategies of innovative companies.
  • Former Deputy Vice President in the International Division of the Pharmaceutical Research and Manufacturers of America (PhRMA)
  • Senior counselor, Genetic Resources and Biotechnology in the Global Issues Division of the World Intellectual Property Organization in Geneva, Switzerland

Michael A. Kowler, CPA/ABV, CVA

Michael A. Kowler is a partner in the Bethesda, Maryland office of Buchbinder Tunick & Company LLP and is the partner-in-charge of the Business Valuation and Forensic Practice. Buchbinder Tunick & Company LLP is a regional CPA firm with offices in New York, New York and Bethesda, Maryland. 

Mr. Kowler has provided auditing, tax consulting and business valuation services to closely-held businesses, family partnerships, and professional practices. Mr. Kowler has provided litigation support services to law firms in cases involving family law matters, shareholder/partner disputes, breach of contracts, lost profit damages, and accounting malpractice. He has qualified as an expert witness State Courts of Maryland and Virginia.

He has prepared business valuations for gift and estate tax compliance and planning, strategic business planning, mergers and acquisitions, marital divorce.
Mr. Kowler has represented clients before the Department of Labor and the Internal Revenue Service.

Ivica Labuda, PhD

BA, Biological Science, University of the Pacific
MS and PhD, Chemical Ecology, University of California, Davis

Professional Experience:

  • Biokeys for Flavors, LLC, Founder and President – contract research company with focus on application of biotechnology in food, food ingredient and flavor industry and food microbiology
  • NovaKera, LLC, Director
  • Adjunct Professor, Biochemistry and Molecular & Cellular Biology & Biotechnology, Georgetown University, Washington, DC
  • Research Associate, NYU, New York, NY
  • Senior Manager, Pepsi Cola, Valhalla, NY
  • Senior Manager, Biotechnology, Danisco Cultor, Ardsley, NY
  • Biotechnology Group Manager, Givaudan, Nutley, NJ
  • Research scientist, Kraft General Foods, Tarrytown, NY
  • Postdoctoral fellow, University of Graz, Austria and Rutgers University, New Brunswick, NJ

Larry Millstein, PhD, JD, Esq

JD, George Mason University School of Law, Arlington, VA
PhD, Chemistry, University of California - San Diego, San Diego, CA

Professional Experience:

  • Millen, White, Zelano & Branigan, PC
  • Chair, Board of Advisors, Biotechnology Program, Georgetown University, Washington, DC
  • President, Philosophical Society of Washington
  • Treasurer, Washington Academy of Sciences
  • Sr. Patent Counsel, Human Genome Sciences, Inc.
  • Consultant, Foley & Lardner
  • Patent Examiner, USPTO
  • President, Society of Fellows, Scripps Research Institute
  • Research Faculty Associate, University of Rochester

Clifford Mintz, PhD

PhD, Bacteriology/Medical Microbiology, University of Wisconsin, Madison, WI

Professional Experience:

  • BioInsights, Inc., CEO and Founder
  • Department of Biology, Chairman
  • Rutgers University, Visiting Scientist
  • Transcell Technologies Inc., Senior Scientist
  • Department of Microbiology and Immunology at the University of Miami School of Medicine, Assitant Professor (Tenure Track)

Mark Mlynarczyk, MBA

MBA, University of Michigan, Ross School of Business

Senior Director, Portfolio Strategy & Operations Company NameAstraZeneca - Global Product & Portfolio Strategy (GPPS)

Hartwell (Phil) Philips, Jr. CPA, CIA

BS Commerce, University of Virginia

Professional Experience:

  • Watkins Meegan, LLC, Member since 1989, regional CPA firm in Washington DC area
  • Prior experience with other accounting firms and financial positions in healthcare industry
  • Expertise in Financial Accounting and Reporting, Auditing and Taxation, Cost Accounting, Government Contracts
  • Current focus is commercial jet aviation fuel management, government contracting and technology firms
  • Also experienced in professional service firms, manufacturing, franchised restaurant operations and various other businesses
  • Member of the Virginia State Board of Accountancy Ethics Committee

Matthew Portnoy, PhD

PhD, Biochemistry, Johns Hopkins University

Professional Experience:

  • Director of the Division of Special Programs, Office of Extramural Programs and the NIH SBIR/STTR Program Coordinator.
  • Program director and SBIR/STTR program coordinator, National Institute of General Medical Sciences

Joseph Shiloach, PhD

PhD, Hebrew University, Israel

Professional Experience:

  • Director, Biotechnology Core Laboratory, NIDDK, National Institutes of Health, Bethesda, MD
  • Adjunct Professor, Department of Chemical Engineering, John Hopkins University, Baltimore, MD
  • Special member on the Graduate Faculty, University of Maryland, College Park, MD
  • Fermentation Director, Biotechnology General Corp.

Sarah Tanksley, MS

MS Regulatory Science, Johns Hopkins University
MS Biochemistry and Molecular Biology, Georgetown University School of Medicine

Professional Experience:

  • Founder & CEO, Tanksley Consulting Group
  • Principal Consultant of Strategic Compliance with PAREXEL Consulting
  • Reviewer/inspector with the Office of Compliance, Center for Biologics Evaluation and Research, FDA.
  • Research lab experience within the National Institute of Allergy and Infectious Diseases, National Institutes of Health, and the U.S. Military.

Stephen Sullivan, MBA

MBA, Rutgers University

Professional Experience:

  • Founder, CRO Advisors, LLC
  • President & CEO, Harlan Laboratories
  • Management positions at Covance, Inc., Xenometric, Abbott Laboratories, Abbott Diagnostics, Baxter International

Guest Lecturers

Anderson Gaweco, MD, PhD

PhD, Immunology, Ruprecht-Karls-Universität Heidelberg, Germany

Professional Experience:

  • President and CEO of Innovimmune Biotherapeutics, Inc
  • Global Clinical Science Leader at Roche and Early Clinical Leader at Pfizer
  • Senior Medical Scientist, Medical Affairs at AstraZeneca
  • Completed management trainings in Executive Leadership Development at London Business School and Biomedical Research at Harvard School of Public Health

Bill Snider, MBA

MBA from the Wharton School at the University of Pennsylvania

Professional Experience:

  • CoFounder & Partner, BroadOak Capital
  • Over 20 years of institutional investment experience
  • General partner and co-founder of Emerging Technology Partners, LLC, a life sciences focused venture capital firm
  • Vice president and portfolio manager at T. Rowe Price
  • Various past directorship at Alpha Innotech and Atto Biosciences
  • Serves on the boards of Molecular Transfer and the MdBio Foundation.

Jay George, PhD

PhD, Georgetown University School of Medicine

Professional Experience:

  • Chief Scientific Officer, Trevigen

Steven Hewitt, MD, PhD

MD at University of Texas Medical School at Houston, and PhD at the University of Texas Graduate School of Biomedical Sciences

Professional Experience:

  • Head, Experimental Pathology, NCI